Drugs / Coriolus Versicolor Extract
Coriolus Versicolor Extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06450873 | Oct 2024 → Dec 2027 expected | Her2-receptor negative breast cancer, estrogen-receptor positive breast cancer | Mayo Clinic | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Coriolus Versicolor Extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06450873 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “In traditional Chinese medicine, it is used for enhancing function and removing toxins, as well as for cancer, hepatitis, and infections.” NCT06450873 ↗ |
| Route | Oral | “Patients receive TTM orally (PO) twice daily (BID)” NCT06450873 ↗ |